These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 161000)

  • 1. Kainic acid binding in human caudate nucleus: effect of Huntington's disease.
    Henke H
    Neurosci Lett; 1979 Oct; 14(2-3):247-51. PubMed ID: 161000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's disease and its animal model: alterations in kainic acid binding.
    Beaumont K; Maurin Y; Reisine TD; Fields JZ; Spokes E; Bird ED; Yamamura HI
    Life Sci; 1979 Feb; 24(9):809-16. PubMed ID: 156298
    [No Abstract]   [Full Text] [Related]  

  • 3. The absence of unique kainic acid-like molecules in urine, serum, and CSF from Huntington's disease patients.
    Beutler BA; Noronha AB; Poon MM; Arnason BG
    J Neurol Sci; 1981 Sep; 51(3):355-60. PubMed ID: 6115893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
    London ED; Yamamura HI; Bird ED; Coyle JT
    Biol Psychiatry; 1981 Feb; 16(2):155-62. PubMed ID: 6452910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
    Dure LS; Young AB; Penney JB
    Ann Neurol; 1991 Dec; 30(6):785-93. PubMed ID: 1665055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]Kainic acid binding and choline acetyltransferase activity in Alzheimer's dementia.
    Pearce BR; Bowen DM
    Brain Res; 1984 Sep; 310(2):376-8. PubMed ID: 6488028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postsynaptic localization of 5-HT1D receptor binding sites in human caudate.
    Gonzalez-Heydrich J; Peroutka SJ
    Exp Neurol; 1991 Jul; 113(1):28-30. PubMed ID: 1828434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.
    Cross AJ; Slater P; Reynolds GP
    Neurosci Lett; 1986 Jun; 67(2):198-202. PubMed ID: 2873534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
    Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease.
    Kremer B; Tallaksen-Greene SJ; Albin RL
    Neurology; 1993 Aug; 43(8):1593-5. PubMed ID: 7688883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic distribution of [3H]kainic acid receptor binding sites in neuronal tissue.
    London ED; Klemm N; Coyle JT
    Brain Res; 1980 Jun; 192(2):463-76. PubMed ID: 6247025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of receptor binding sites for [3H]glutamic acid and [3H]kainic acid in the rat cerebellum.
    Slevin JT; Coyle JT
    J Neurochem; 1981 Aug; 37(2):531-3. PubMed ID: 6114990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease.
    Schwarcz R; Bennett JP; Coyle JT
    J Neurochem; 1977 Apr; 28(4):867-9. PubMed ID: 142820
    [No Abstract]   [Full Text] [Related]  

  • 14. L-glutamate specific [3H]kainic acid binding in the rat neostriatum after degeneration of the cortico-striatal pathway.
    Henke H; Cuénod M
    Neurosci Lett; 1979 Mar; 11(3):341-5. PubMed ID: 229440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for interactions between [3H]glutamate and [3H]kainic acid binding sites in rat striatal membranes. Possible relevance for kainic acid neurotoxicity.
    Fuxe K; Agnati LF; Celani MF
    Neurosci Lett; 1983 Mar; 35(3):233-8. PubMed ID: 6843895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and persistence of kainic acid in brain.
    Scherer-Singler U; McGeer EG
    Life Sci; 1979 Mar; 24(11):1015-22. PubMed ID: 449605
    [No Abstract]   [Full Text] [Related]  

  • 17. Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex.
    Reynolds GP; Pearson SJ; Heathfield KW
    Neurosci Lett; 1990 May; 113(1):95-100. PubMed ID: 1973277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing characteristics between glutamate and kainic acid binding sites in brain synaptic membranes.
    Michaelis EK; Michaelis ML; Grubbs RD
    FEBS Lett; 1980 Aug; 118(1):55-7. PubMed ID: 7409191
    [No Abstract]   [Full Text] [Related]  

  • 19. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.
    Higatsberger MR; Sperk G; Bernheimer H; Shannak KS; Hornykiewicz O
    Exp Brain Res; 1981; 44(1):93-6. PubMed ID: 6456150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.